After 10 weeks of the Antler Japan Residency Program 3, we are proud to announce that our co-founders, Joshua and Tetsuro, have successfully completed the program.
By ModAstera
18 Dec 2024
We are proud to announce that our co-founders, Joshua and Tetsuro, participated in the Antler Japan Residency Program 3. After 10 weeks of the program, they have successfully completed the program. ModAstera is now a part of the Antler Japan family. ModAstera will continue receive support from Antler Japan while working on our mission to accelerate the development of healthcare AI.
ModAstera and Wellgen Medical are partnering to build AI screening models for cancer cytology, combining FDA-cleared tomographic imaging, clinical datasets, and rapid medical AI deployment.
ModAstera welcomes Prof. Christian Aldridge, a leading UK dermatologist and skin cancer authority, as Chief Medical Officer to drive clinical governance across Hebra and MAEA.
ModAstera participated in the Qualcomm AI Program for Innovators (QAIPI) 2025 APAC Demo Day in Seoul, showcasing our vision for secure, privacy-preserving medical AI and deepening collaboration within the global AI ecosystem.
